[Effect of 15-me-prostaglandin F2 alpha on the release of endogenous prostaglandin F2 alpha and the concentration of estrogen and progesterone receptors in the human endometrium].
D000019:Abortifacient Agents; D000020:Abortifacient Agents, Nonsteroidal; D000028:Abortion, Induced; D000293:Adolescent; D000328:Adult; D015237:Dinoprost / Q000031:analogs & derivatives; D004717:Endometrium / Q000032:analysis*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011460:Prostaglandins F / Q000378:metabolism*; D011461:Prostaglandins F, Synthetic; D011960:Receptors, Estrogen / Q000032:analysis*; D011980:Receptors, Progesterone / Q000032:analysis*
D000019:Abortifacient Agents; D000020:Abortifacient Agents, Nonsteroidal; D011460:Prostaglandins F; D011461:Prostaglandins F, Synthetic; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C030319:prostaglandin F2alpha 15-methyl ether; D015237:Dinoprost
Vliianie 15-me-prostaglandina F2 alpha na vydelenie éndogennogo prostaglandina F2 alpha i soderzhanie retseptorov éstrogenov i progesterona v éndometrii zhenshchin.